300 related articles for article (PubMed ID: 24403290)
1. Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.
Majumdar D; Jung KH; Zhang H; Nannapaneni S; Wang X; Amin AR; Chen Z; Chen ZG; Shin DM
Cancer Prev Res (Phila); 2014 Jan; 7(1):65-73. PubMed ID: 24403290
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.
Amin AR; Wang D; Zhang H; Peng S; Shin HJ; Brandes JC; Tighiouart M; Khuri FR; Chen ZG; Shin DM
J Biol Chem; 2010 Nov; 285(45):34557-65. PubMed ID: 20826787
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of head and neck cancer.
Glover KY; Papadimitrakopoulou VA
Curr Oncol Rep; 2003 Mar; 5(2):152-7. PubMed ID: 12583833
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a copolymer carrier for anticancer drug luteolin for targeting human breast cancer cells.
Mahin M; Ali A; Elahe K; Naser A; Elahe K; Shaahin S; Nader S; Naser A
J Tradit Chin Med; 2019 Aug; 39(4):474-481. PubMed ID: 32186094
[TBL] [Abstract][Full Text] [Related]
5. Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma.
Wu G; Li J; Yue J; Zhang S; Yunusi K
Mol Med Rep; 2018 Feb; 17(2):2456-2464. PubMed ID: 29207088
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention targets for tobacco-related head and neck cancer: past lessons and future directions.
Sheth SH; Johnson DE; Kensler TW; Bauman JE
Oral Oncol; 2015 Jun; 51(6):557-64. PubMed ID: 25868717
[TBL] [Abstract][Full Text] [Related]
7. A perspective on chemoprevention by resveratrol in head and neck squamous cell carcinoma.
Shrotriya S; Agarwal R; Sclafani RA
Adv Exp Med Biol; 2015; 815():333-48. PubMed ID: 25427916
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of squamous cell carcinoma of the head and neck.
Wrangle JM; Khuri FR
Curr Opin Oncol; 2007 May; 19(3):180-7. PubMed ID: 17414634
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials in chemoprevention of head and neck cancers.
Feng L; Wang Z
Rev Recent Clin Trials; 2012 Aug; 7(3):249-54. PubMed ID: 22540907
[TBL] [Abstract][Full Text] [Related]
10. A Review of Promising Natural Chemopreventive Agents for Head and Neck Cancer.
Crooker K; Aliani R; Ananth M; Arnold L; Anant S; Thomas SM
Cancer Prev Res (Phila); 2018 Aug; 11(8):441-450. PubMed ID: 29602908
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of head and neck cancer with green tea polyphenols.
Kim JW; Amin AR; Shin DM
Cancer Prev Res (Phila); 2010 Aug; 3(8):900-9. PubMed ID: 20663981
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.
Zhang X; Zhang H; Tighiouart M; Lee JE; Shin HJ; Khuri FR; Yang CS; Chen Z'; Shin DM
Int J Cancer; 2008 Sep; 123(5):1005-14. PubMed ID: 18546267
[TBL] [Abstract][Full Text] [Related]
13. Model examination of chemoprevention with retinoids in squamous cell carcinomas of the head and neck region and suitable biomarkers for chemoprevention.
Fabricius EM; Kruse-Boitschenko U; Schneeweiss U; Wildner GP; Hoffmeister B; Raguse JD
Int J Oncol; 2011 Nov; 39(5):1083-97. PubMed ID: 21785820
[TBL] [Abstract][Full Text] [Related]
14. Prevention of head and neck squamous cell carcinoma: removing the "chemo" from "chemoprevention".
Saba NF; Haigentz M; Vermorken JB; Strojan P; Bossi P; Rinaldo A; Takes RP; Ferlito A
Oral Oncol; 2015 Feb; 51(2):112-8. PubMed ID: 25434586
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of cancers of the oral cavity and the head and neck.
Sankaranarayanan R; Mathew B; Nair PP; Somanathan T; Varghese C; Jyothirmayi R; Krishnan Nair M
IARC Sci Publ; 1996; (136):13-25. PubMed ID: 8791111
[No Abstract] [Full Text] [Related]
16. A population-based trial of beta-carotene chemoprevention of head and neck cancer.
Mayne ST; Zheng T; Janerich DT; Goodwin WJ; Fallon BG; Cooper DL; Friedman CD
Adv Exp Med Biol; 1992; 320():119-27. PubMed ID: 1442276
[No Abstract] [Full Text] [Related]
17. Chemoprevention in head and neck cancer.
Mellott A; Vokes E
Cancer Treat Res; 2001; 106():221-35. PubMed ID: 11225004
[No Abstract] [Full Text] [Related]
18. Luteolin induces apoptosis by activating Fas signaling pathway at the receptor level in laryngeal squamous cell line Hep-2 cells.
Zhang H; Li X; Zhang Y; Luan X
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1653-9. PubMed ID: 24477342
[TBL] [Abstract][Full Text] [Related]
19. Antitumor Efficacy of Liposome-Encapsulated NVP-BEZ235 Combined with Irreversible Electroporation for Head and Neck Cancer.
Tian L; Wang L; Qiao Y; Lu L; Lee P; Chang A; Ravi S; Rogers TA; Melancon MP
Molecules; 2019 Oct; 24(19):. PubMed ID: 31581445
[TBL] [Abstract][Full Text] [Related]
20. In vivo controlled release of fenretinide from long-acting release depots for chemoprevention of oral squamous cell carcinoma recurrence.
Nieto K; Pei P; Wang D; Mallery SR; Schwendeman SP
Int J Pharm; 2018 Mar; 538(1-2):48-56. PubMed ID: 29170116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
